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The effect of early myocardial reperfusion (within 4 hours 
after onset of symptoms) on regional left ventricular 
function in patients with acute myocardial infarction has 
been quantitated by analysis of segmental wall motion. 
Of 533 patients randomized either to conventional coro•
nary care unit therapy or to a reperfusion strategy, in 
332 high quality angiograms were obtained 2 to 8 weeks 
after the onset of myocardial infarction. In those as•
signed to thrombolytic therapy, angiographic data were 
also available after acute reperfusion. Analysis on an 
"intention to treat" basis revealed significant preser•
vation of left ventricular function after thrombolytic 
therapy (ejection fraction 53%) compared with conven-
Since the clinical investigations of Rentrop et al. (1), many 
studies have confirmed that acutely occluded coronary ar•
teries in patients with acute myocardial infarction can be 
recanalized by intracoronary infusion of thrombolytic agents 
(2), It is assumed that early reestablishment of anterograde 
flow can prevent myocardium, rendered temporarily isch•
emic by coronary thrombotic occlusion, from progressing 
to complete necrosis, Animal experiments have shown that 
timely restoration of coronary blood flow can salvage myo•
cardium (3-6) and improve survival (4). However, reported 
human data are still conflicting, largely because of differ-
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tional treatment (ejection fraction 47%). In addition, 
wall motion analysis showed significant improvement of 
regional function in the infarct zone in both inferior and 
anterior infarction. In addition, significant changes oc•
curred in regional function of the remote "noninfarct 
zone" in the acute as well as the chronic stage. It is 
concluded that improved regional and global left ven•
tricular function can be achieved with early reperfusion 
and that this is the likely explanation for the reduction 
of early and late mortality after thrombolysis observed 
in this study. 
(J Am Coil CardioI1986;7:729-42) 
ences in the dose and route of administration of the throm•
bolytic agent and because of the long intervals between the 
onset of symptoms and reperfusion, Furthermore, the risks 
of undergoing angiography in the first hours of myocardial 
infarction are not negligible (7) and may even outweigh the 
potential benefits of recanalization in some patients. Re•
perfusion of ischemic myocardium has been shown to cause 
arrhythmias (8), intramyocardial hemorrhage (9,10) and cal•
cium overload of myocardial cells with subsequent death as 
a result of rapid reperfusion (the oxygen paradox) (11). All 
these factors may negate the beneficial effects of reperfusion, 
To determine whether thrombolysis is a clinically useful 
approach in acute myocardial infarction, a randomized trial 
was started in June 1981. This report details the analysis of 
the influence of myocardial reperfusion on left ventricular 
function after attempted recanalization in comparison with 
similar studies in patients randomly assigned to conventional 
treatment. Follow-up data from this study have been pub•
lished recently (12) and demonstrated improved 1 year sur-
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730 SERRUYS ET AL 
LEFf VENTRICULAR FUNCTION AFfER THROMBOLYSIS 
vival after thrombolysis (91 %) compared with conventional 
treatment (84%. p = 0.01). This improved survival is as•
sociated with a limitation of infarct size. estimated from 
myocardial enzyme release. and with preservation of global 
left ventricular function measured by radionuclide angiog•
raphy (12a). 
In the randomized trials published thus far (13-19). the 
assessment of global ejection fraction has prevailed because 
it is relatively easily obtainable. However, improvement in 
global left ventricular function after successful recanaliza•
tion might be attributed to several factors: salvage of jeop•
ardized myocardium. compensatory hyperactivity of op•
posite wall segments (20.21) or changes in preload and 
afterload. In an effort to unravel these factors. the effect of 
myocardial reperfusion on left ventricular function was ana•
lyzed by measuring systolic regional wall motion along 20 
coordinates. 
Methods 
Patient selection. This randomized trial of thrombolysis 
in acute myocardial infarction is a multicenter study sup•
ported by the Interuniversity Cardiology Institute in the 
Netherlands. The protocol and some initial results were 
published in 1982 (7,22-24). Because preliminary data 
(25-27) indicated that reocclusion of the coronary artery 
occurred predominantly in patients with severe residual ste•
nosis. immediate percutaneous transluminal coronary an•
gioplasty was added to the procedure in those patients in 
whom visual inspection of the coronary arteriograms sug•
gested residual stenosis in excess of 60%. When it also 
became evident that possibly crucial time was lost by prep•
aration for catheterization. while other studies (28-30) re•
ported angiographic confirmation of thrombolysis after in•
travenous streptokinase infusion. it was decided (January 
1984) to give intravenous streptokinase (500,000 U) at the 
time of hospital admission. This meant that thrombolytic 
therapy was begun approximately I hour before intracoro•
nary streptokinase could be started in the treatment arm. 
Admission to the study was discontinued in March 1985. 
During the study period all patients up to the age of 70 
years with chest pain and electrocardiographic signs of typ•
ical myocardial infarction who were admitted within 4 hours 
after the onset of symptoms were eligible for the trial. The 
usual exclusion criteria for thrombolytic therapy were ap•
plied as described in detail in previous reports (l2a,22-24). 
The protocol is summarized in Figure I. After inclusion, 
the 533 patients were registered by a central telephone an•
swering service that also provided treatment allocation (l2a). 
Informed consent was obtained from the 269 patients al•
located to thrombolytic therapy only, as proposed by Zelen 
(31). Patients who refused consent were treated according 
to the same guidelines as the control group (32). 
Conventional treatment in all patients was directed 
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day 1 admiSSion CGU 
symptoms < 4h + tYPical EGG .. 
randomization 
i.c streptokinase 
LV angiogram 
Swan Ganz cath Swan Ganz cath 
day 2 
---------GGU serial ECG + enzymes .. 
day 10 - 14 exercise test 
blood - pool scintigraphy 
recatheterization 
Figure 1. Flow chart of the procedures in the current randomized 
trial at the Thoraxcenter and other members of the Interuniversity 
Cardiological Institute. cath = catheterization; CCU = cardiac 
care unit: ECG = electrocardiogram: i.c. = intracoronary; LV 
= left ventricular. 
toward rapid achievement of an "optimal" hemodynamic 
state characterized by light sedation, heart rate between 60 
and 90 beats/min, systolic blood pressure between 100 and 
140 mm Hg and the absence of signs of left ventricular 
failure or a pulmonary capillary wedge pressure below 12 
mm Hg. 
All patients were treated with heparin followed by acen•
ocoumarol (Sintrom) until hospital discharge. After dis•
charge. anticoagulant agents were continued only in patients 
with ventricular aneurysm, intraventricular thrombus. mitral 
incompetence or a large ventricle with a poor contraction 
pattern. Metoprolol, 100 mg two times daily. was prescribed 
in the majority of patients from the 7th to the 14th study 
day onward unless contraindications were present. 
Reperfusion protocol. In the 269 patients assigned to 
streptokinase treatment, nitroglycerin infusion (100 JLg/min) 
was started immediately and the patients were transferred 
to the catheterization laboratory as soon as possible. Lido•
caine was given intravenously in a dose of 2 mg/min. After 
puncture of the femoral vein and artery, a pacemaker cath•
eter was positioned in the right ventricle. Next, coronary 
arteriography of the artery suspected to be thrombosed was 
performed. No evaluation of the collateral circulation was 
performed before thrombolysis because such effort would 
have postponed the actual onset of recanalization and per•
haps reduced its possible benefit. The disastrous conse•
quence of injection of ionic contrast medium into the con•
tralateral artery, particularly when it is the right coronary 
artery, has been previously reported (7). After identification 
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of the thrombosed coronary branch, 5,000 U heparin was 
administered intravenously together with 250 mg of ace•
tylsalicyclic acid and 100 mg of a corticosteroid (Diadreson 
F), in order to reduce possible antigenic effects of strep•
tokinase. 
Intracoronary perfusion was carried out at a rate of 4,000 
U/min to a maximum of 250.000 U streptokinase, diluted 
in 500 ml of physiologic solution, at a flow rate of 8 mllmin. 
Coronary angiograms were repeated every 15 minutes until 
the vessel was patent or the chest pain had disappeared. The 
appearance or reappearance of ventricular extrasystoles or 
any conduction disturbance was also an indication to revis•
ualize the artery. If there were no signs of recanalization. 
an attempt was made to administer streptokinase locally in 
a higher concentration by passing a thin catheter with a 
radiopaque tip through the Judkins catheter (8F). 
After completion of the streptokinase infusion, the nitro•
glycerin and lidocaine infusions were interrupted and com•
plete left and right coronary arteriography was performed. 
If the clinical condition was stable with left ventricular end•
diastolic pressure below 35 mm Hg, left ventriculography 
was performed in the right anterior oblique projection. Coro•
nary arteriography and left ventricular angiography were 
performed in both the control and thrombolysis-treated groups, 
either before hospital discharge or 4 to 8 weeks after the 
acute phase of infarction. 
Analysis of global and regional left ventricular func•
tion. Global and regional left ventricular function was stud•
ied from the 30° right anterior oblique left ventricular ci•
neangiogram with an automated hard-wired endocardial 
contour detector linked to a minicomputer (33). For each 
analyzed cineframe, left ventricular volume was computed 
according to Simpson's rule. After the end-diastolic and 
end-systolic frames were determined. stroke volume, global 
ejection fraction and total cardiac index were computed. 
Figure 2A shows an example of the end-diastolic and end•
systolic contours of the left ventriculogram, as displayed by 
the analysis system. Systolic regional wall displacement is 
determined along a system of 20 coordinates based on the 
pattern of actual endocardial wall motion in normal indi•
viduals (34), and generalized as a mathematical expression 
amenable to automatic data processing (23,35). 
For each segment. segmental volume is computed from 
the local radius (R) and the height of each segment (1110 
of left ventricular long-axis length (L) according to the for•
mula: 1120 n R2L). When normalized for end-diastolic vol•
ume, the systolic segmental volume change can be consid•
ered as a variable of regional pump function (Fig. 2B and 
C). During systole this variable expresses quantitatively the 
contribution of a particular segment to global ejection frac•
tion, termed regional contribution to global ejection fraction 
(24). The sum of the values for all 20 segments equals the 
global ejection fraction. The hatched zones in Figure 2D 
represent the segmental values of this variable between the 
10th and 90th percentiles, as determined in 20 normal in-
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dividuals. The regional contribution to ejection fraction in 
the anterobasal (segments I to 5). anterolateral (segments 
5 to 9), apical (segments 9, 10. 11 and 12), inferior (seg•
ments 12 to 16) and posterobasal (segments 16 to 20) wall 
regions was compared in the control group and thrombolysis 
groups. 
Statistics. Data are expressed as mean ± SD. Paired or 
unpaired Student's t tests were applied to the hemodynamic 
data whenever appropriate and differences in baseline char•
acteristics between groups were tested by Fisher's exact test. 
Results 
Early and late angiography. A total of 533 patients 
were admitted to the trial in five participating hospitals; 264 
patients were allocated to conventional therapy and 269 
patients to thrombolysis. In 35 patients allocated to throm•
bolysis, angiography could not be performed because 
informed consent was refused (20 patients), a contraindi•
cation occurred before angiography (1 patient), the coronary 
could not be reached from the femoral artery (6 patients) 
or pain and ST elevation resolved shortly after randomi•
zation (5 patients). 
Of 234 patients who underwent early angiography (Table 
I), 65 had a patent infarct -related coronary artery and in 
169 this artery was occluded. In 136 patients undergoing 
catheterization without previous intravenous streptokinase 
infusion. the infarct-related vessel was occluded in 111 (82%) 
and recanalization was achieved in 88 (79%) of these after 
30 minutes (median) of intracoronary infusion of strepto•
kinase. An occluded artery was found in 58 (59%) of 98 
patients who received intravenous streptokinase before its 
intracoronary administration. Subsequently, intracoronary 
streptokinase caused recanalization in 39 patients while in 
5 the thrombus was perforated by guidewire or angioplasty 
catheter. Ultimately, the infarct-related artery remained oc•
cluded in 36 of 234 patients who underwent angiography 
and at least one attempt at recanalization (15%), and the 
artery was open at study time or became recanalized in 198 
patients (85%). In addition, trans luminal coronary angio•
plasty succeeded in 44 of 46 patients in whom it was at•
tempted. The median time between onset of symptoms and 
angiographic documentation of a patent infarct-related ves•
sel was 200 minutes (Table 2). 
Follow-up angiograms of high quality were available in 
332 of the 533 patients. These data were missing in 42 
patients who died in the intervening period, 24 who under•
went early bypass surgery, 23 who were transferred to an•
other hospital and 41 who refused the second angiographic 
study: in 71 patients angiograms were obtained, but were 
inadequate for quantitative analysis. The angiograms that 
were available in 332 patients are described in this report. 
These angiograms were made before discharge in 279 pa•
tients (median 11 days after entry) and after discharge in 
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Figure 2. A, Example of the computer output showing the end•
diastolic and end-systolic contours of the 30° right anterior oblique 
left ventriculogram and the system of 20 coordinates along which 
left ventricular segmental wall displacement is determined. B, The 
left ventricular end-diastolic cavity is divided into 20 half slices. 
The volume of each half slice is computed according to the formula 
Y20 1T R2L, where R is radius and L is left ventricular long-axis 
length. C, The regional contribution to global ejection fraction is 
determined from the systolic decrease of volume of the half slice 
which corresponds to a particular wall segment. The systolic vol•
ume change is mainly a consequence of the decrease of radius (R) 
of the half slice. ED = end-diastolic; ES = end-systolic. D, The 
shaded zones represent the 10th to 90th percentile areas of values 
of regional contribution to global ejection fraction in normal in•
dividuals. On the x axis the global ejection fraction values of the 
anterior and inferoposterior wall areas are displayed (%), while 
on the y axis the segment numbers of the anterior wall (I to 10) 
and of the inferoposterior wall (II to 20) are depicted. 
124 patients (median 42 days after entry). During follow•
up angiography, the rate of vessel patency in the control 
group and thrombolysis group was, respectively, 52% (90 
of 174) and 77% (122 of 158)(p = 0.0001). The reocclusion 
rate in patients with arterial recanalization by intracoronary 
streptokinase was 21 % (19 of 91 patients), while late oc•
clusion in the patients with a patent infarct-related vessel at 
first angiogram was 6% (2 of 36 patients). Baseline data in 
Table 3 were comparable in both groups. 
Global left ventricular function: thrombolysis versus 
conventional treatment. When the hemodynamic data of 
the control group are compared with those of the throm•
bolysis group, almost all the variables listed in Table 4 show 
significant differences. The global left ventricular ejection 
fraction in the thrombolysis group was on average 6% higher 
(p = 0.0001) than in the control group, a difference mainly 
due to a smaller end-systolic volume in the thrombolysis 
group (41 versus 53 ml!m2 in the control group, p = 0.0004). 
In addition, the end-dtastolic volume was significantly higher 
and abnormal in the control group compared with the throm•
bolysis group (95 versus 84 mllm2, p = 0.006) whereas 
mean aortic pressure and heart rate were not different at the 
time of the hemodynamic investigation. In TatJle 5 the 
hemodynamic data of both groups are shown after exclusion 
of those 65 patients who had had a previous infarction (40 
in the control group and 25 in the thrombolysis group). The 
differences observed between conventional or thrombolytic 
therapy in the entire group of 332 patients remain present 
to a significant degree, but in the thrombolysis group, the 
ejection fraction is now 6% higher (p = 0.0002) than in 
the control group, while the end-systolic volume is 10 mllm2 
smaller (p = 0.0015) than in the control group. 
lACC Vol 7. No.4 
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No Late Angiography 
733 
(not performed or data missmg) 
Group Early Angiography 
Control 
(n = 264) 
35 no early angiography 
ThrombolysIs ?- 65 0 ~ 65 0 
(n = 269) "----
~169 e~ 1330 
~36e 
Total (n = 533) 
Patient 
Refusal 
19 
5 
II 
5 
41 
Death CABG 
27 4 
4 2 
9 
4 4 
6 5 
42 24 
Inadequate 
Quality of 
LV 
Late Angiography 
Angiogram Other 0 e 
31 9 90 84 
8 2 6 8 
13 5 34 2 
17 6 72 19 
2 10 7 
71 23 212 120 
Patent vessels are indicated by (0) and occluded vessels by (e). CABG = patients without late angiography because of coronary bypass surgery; 
death = patIents who died before late angiography was performed. LV = left ventricular; other = other missing data, for example, because of transfer 
to another hospital 
Because angiography was not performed in the control 
group initially, it might be argued that the thrombolysis 
group had a more favorable outcome because of the higp,er 
incidence (28%) of subtotally occluded vessels. Although 
the randomized approach makes this bias unlikely, we ana•
lyzed separately th~ outcome of patients with subtotal oc•
clusion and compared it with results in patients in whom 
reperfusion of totally occluded vessels was achieved during 
catheterization. The actual beneficial effects of reperfusion 
in these patients with total occlusion are clearly demon•
strated in Table 4; the hemodynamic outcome of these pa•
tients did not differ from the outcome of the group with 
subtotal occlusion. 
Global and segmental function in anterior or inferior 
infarction: thrombolysis versus conventional treatment. 
Table 6 and Figure 3 present the data on patients with 
inferior infarction. The global ejection fraction shows an 
8% difference (p = 0.0001) in favor of the thrombolysis 
group and this difference in ejection fraction is due to a 
significantly smaller (p = 0.007) end-systolic volume (37 
ml!m2) when compared with the end-systolic volume of the 
Table 2. Time Between Onset of Symptoms 
and Thrombolysis in 127 Patients With Late 
Angiography 
Range 
First quartile 
Median 
Third quartile 
Minutes 
70 to 240 
160 
200 
255 
control group (48 ml!m2). In Figure 3A, the regional con•
tribution to ejection fraction values of the patients with 
inferior infarction assigned to thrombolysis is compared with 
that of patients assigned to conventional treatment. De•
pressed regional contribution to ejection fraction values was 
observed in the inferoposterior wall (segments 11 to 18) as 
expected, while regional pump function was significantly 
better in patients assigned to thrombolysis, although not 
(yet) normal. In these patients no difference was observed 
in regional function of the anterior wa1l. Thus, when re•
canalization is successful and the infarct-related vessel re•
mains patent, there is a significant improvement of function 
of the inferior wall associated with the subsidence of the 
initially compensatory augmented functioning of the anterior 
wall. This latter phenomenon was particularly prominent in 
the patients who underwent the combined procedure of re•
canalization and angioplasty (Fig. 3B) in the acute phase. 
Global and regional left ventricular function of patients 
with anterior myocardial irifarction is shown in Table 7 and 
Figure 4. A significant (p = 0.0025) 7% difference in global 
ejection fraction is found between both groups because of 
a smaller end-systolic volume of 45 mllm2 in the throm•
bolysis grQup versus 60 mllm2 in the control group (p = 
0.006). As Figure 4A clearly indicates, this 7% difference 
in global ejection fraction in favor of the thrombolysis group 
is essentially due to a better regional pump function of the 
anterior wall (segments I to 20) and, to a smaller extent, 
better regional pump function of the inferoapical segment 
(segments 11-15) of the inferior wall. 
The preceding analysis was based on original treatment 
allocation. disregarding whether treatment was actually given 
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Table 3. Baseline Data in Patients With and Without Follow-up Angiography 
Follow-up AngIography No Follow-up Angiography 
Control Thrombolysis Control Thrombolysis 
Group Group Group Group 
No. of patIents 174 158 90 III 
Male 152 130 72 87 
Age (mean ± SO) 55 ± 8 55 ± 10 55 ± 9 57 ± 9 
Previous mfarctlOn 40 (23) 25 (16) 20 (22) 31 (28) 
Previous bypass surgery 6 (3) 20l 2 (2) 3 (3) 
Infarction 
Anterior wall 69 (40) 79 (50) 47 (52) 51 (46) 
Inferior wall 105 (60) 79 (50) 43 (48) 60 (54) 
The number 10 each group IS presented as well as the percentage (%). 
and whether reperfusion was achieved. The actual effects 
of reperfusion can be better understood when four subgroups 
of patients are compared: a) patients who refused the in•
tervention or otherwise did not undergo acute angiography. 
b) patients with either unsuccessful recanalization or late 
reocclusion, c) patients with successful recanalization and 
late patency of the infarct-related vessel, and d) patients 
who underwent succes~ful recanalization, immediately fol•
lowed by angioplasty. Segmental function of the anterior 
wall was poorest in patients whose artery could not be re•
canalized, and greatest in those patients who underwent a 
combined procedure of thrombolysis and angioplasty (Fig. 
3D and 4D). The magnitude of change in regional function 
at the infarct site was also related to the time from the onset 
of chest pain to treatment. Patients treated with t~rombolytic 
therapy within 3 hours of symptoms had a significantly 
greater improvement than did patients treated later (Fig. 3C 
and 4C). The regional contribution to ejection fraction of 
the infarct zone, either anterior or inferior, improved by at 
least 1.5% in the group treated early. 
Serial changes in global and segmental f .. nction in 
patients Illlocated to thrombolytic therapy. Eighty-two 
of the patjents allocated to thrombolytic therapy had left 
ventriculograms performed in the acute phase of myocardial 
infarction and at a follow-up catheterization. Table 8 pre•
sents the serial changes in global left ventricular function 
of the patients with anterior and inferior infarction. After 
successful recanalization, no significant change in ejection 
fraction could be demonstrated. In the patients with inferior 
infarction, the improvement of the inferior wall observed 
between the acute and chronic stage was partially masked 
by the disappearance of the compensatory actions of the 
initially enhanced function of the anterior waIl (Fig. 3B). 
Conversely, when recanalization was unsuccessful. a sig•
nifj.cant deterioration of the global variables of function re•
sulted: a decrease of 4% in ejection fraction (p = 0.004) 
and an increase in end-systolic volume from 37 to 48 mllm2 
(p = 0.0006) and in end-diastolic volume from 74 to 93 
mllm2 (p = 0.0003). 
Similar trends were observed in the patients with anterior 
Table 4. Left Ventricular Hemodynamics Before Discharge (n = 332) 
Controls Thrombolysis 
(n = 174) P Value (n = 158) 
HR (bpm) 78 ± 15 NS 76 ± 13 
Mean AoP (mm Hg) 88 ± 13 NS 90 ± 15 
EOP (mm Hg) 20 ± 9 NS 20 ± 8 
EOY (!I1l/m2) 95 ± 37 0.006 84 ± 33 
ESV (mllm2) 53 ± 31 0.0004 41 ± 27 
EF(%) 47 ± 14 0.0001 53 ± 13 
SV (ml/m2) 42 ± 16 NS 43 ± 15 
CI (liters/min per m2) 3.3 ± 1.3 NS 3.2 ± 1.1 
None 
(n = 14) 
94 ± 42 
48 ± 29 
50 ± 12 
0---0 
(n = 36) 
80 ± 24 
36 ± 17 
56 ± 11 
I 
NS 
NS 
NS 
Artery at Angiography* 
.---0 
(n = 91) 
81 ± 30 
40 ± 23 
54 ± 12 
.---. 
(n = 17) 
96 ± 46 
58 ± 46 
45 ± 16 
L--p = 0.04~ 
p = 0.02 
Values are expressed as mean ± SO; Student t test for unpaired data. Only p values below 0.1 are tabulated. AoP = aortic pressure; CI = cardiac 
index; EOP = end-diastolic pressure; EOV = end-diastolic volume; EF = ejection fraction; ESV = end-systolic volume; HR = heart rate; None = 
no acute angIography performed; SV = stroke volume. *0---0 = patent artery at angiography remamed patent; .---0 = occluded artery recanalized 
after the interventIOn; .---. = occluded artery remained occluded. 
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Table 5. Left Ventricular Hemodynamics Before Discharge in Patients Without Previous 
Myocardial Infarction 
HR (bpm) 
Mean AoP (mm Hg) 
EDP (mm Hg) 
EDV (mlim2) 
ESV (mlim2) 
EF(%) 
SV (ml/m2) 
CI (hters/min per m2) 
Ahbreviation~ a; in Table 4. 
Control> (n = 134) 
77 :±: 13 
88 :±: 13 
19 :±: 9 
91 :±: 37 
48 :±: 29 
49 :±: 13 
43 ::+: 17 
3.3 ::+: 1.2 
infarction, In these 82 patients serial changes in regional 
contribution of the infarct zone to ejection fraction were 
studied according to the success of thrombolysis either with 
or without angioplasty (Fig, 5), In the angioplasty group. 
global ejection fraction increased significantly (p == 0,03) 
from 51 to 55% from the acute to the chronic stage. an 
improvement primarily due to a 16% increase in the value 
of the regional contribution to ejection fraction of the infarct 
zone, In the patients undergoing successful thrombolysis 
without angioplasty. the global ejection fraction remained 
unchanged at 57% and was associated with a small increase 
of 1.7% in the value of the regional contribution to ejection 
fraction of the infarct zone. Conversely. in patients with 
unsuccessful thrombolysis, the global ejection fraction ac•
tually decreased significantly from 53 to 49% (p = 0,03). 
a change consistent with the II % decrease in the value of 
the regional contribution to ejection fraction of the infarct 
zone. 
Discussion 
Results of thrombolysis versus conventional ther•
apy. The results of the present study show, for the first 
time in a large randomized multicenter trial, that early re•
canalization of an occluded coronary artery in the acute 
phase of myocardial infarction is followed by preservation 
of global and regional left ventricular function, Whereas in 
most patients randomly assigned to conventional treatment, 
Thrombolysis (n = 133) P Value 
75 :±: 13 NS 
90 :±: IS NS 
19 :±: 9 NS 
82 :±: 31 0.03 
38 :±: 22 00015 
55 :±: 12 0.0002 
44 :±: IS NS 
3.3 :±: 1.2 NS 
left ventricular function deteriorated. the heart in treated 
patients maintained normal end-diastolic and end-systolic 
volumes. thus explaining their normal ejection fraction, 
These results are in agreement with the findings of our 
pilot study (36) in which left ventricular function was as•
sessed sequentially. at the acute and chronic stage of in•
farction, in patients with "successful" or "unsuccessful" 
recanalization, Similar results have been reported in pre•
vious studies (37-43), From these nonrandomized studies 
it appeared that patients with "successful" recanalization 
had a higher global ejection fraction (by 5 to 12%) compared 
with those with "unsuccessful" recanalization or conven•
tional treatment. Also. it appeared that left ventricular dam•
age was less in those patients who demonstrated spontaneous 
recanalization of the infarct-related vessel 4 to 6 weeks after 
the acute event (40), Schwartz et ai, (41) found improvement 
of left ventricular function only when recanalization was 
achieved within 4 hours, Rentrop et aL (42) suggested that 
improved left ventricular function after thrombolysis oc•
curred only in patients with collateral vessels, those with 
incomplete obstruction before intervention and those in whom 
complete obstruction was permanently rec anali zed , Al•
though all of these studies have aroused great interest, their 
interpretation is difficult. as selected patients with successful 
thrombolysis were compared with patients with persistent 
coronary occlusion, Such interpretation can carry consid•
erable bias, because patients in whom thrombolysis suc•
ceeded are not necessarily similar to those in whom the 
Table 6. Left Ventricular HemodynamICs in Inferior Infarction Before Discharge 
Controls (n = 105) Thrombolysis (n = 79) P Value 
HR (bpm) 77 :±: 16 74 :±: 12 NS 
Mean AoP (mm Hg) 88 ::+: 13 91 ± 15 NS 
EDP (mm Hg) 19 :±: 8 18 :±: 8 NS 
EDV (mlim2) 91 ± 35 82 ± 32 0.07 
ESV (ml/m2) 48 :±: 28 37 ± 24 0.007 
EF (%) 49 :±: 13 57 :±: II 0.0001 
SV (mlim2) 43 :±: 16 44 ± 15 NS 
CI (hters/mm per m2) 3.3 :±: 1.3 3.3 ± 1.2 NS 
Abbreviations as in Table 4. 
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Figure 3. A, Regional contribution to global ejection fraction in 
20 segments of the left ventriculogram in patients with inferior 
infarction. Shaded areas represent the normal range. The regional 
pump function of the inferior wall (segments 11 to 20) in the 
thrombolysis treated group (n = 79, solid line) is markedly less 
depressed than in the conventionally treated group (n = 105, 
dotted lines). P = P value; NS = nonsignificant. B, Change in 
regional contribution to global ejection fraction from the acute 
(solid line) to the chronic (dotted line) stage in patients (n = 6) 
with an inferior infarction who underwent a combined procedure 
of thrombolysis and angioplasty. C, Regional contribution of the 
inferior wall to global ejection fraction at the chronic stage in the 
control group and in the thrombolysis group, according to the 
success of the recanalization at the acute stage and to the time 
elapsed from the onset of symptoms to treatment. -. - = Control 
(n = 105); '" = thrombolysis> 180 minutes (n = 41); - == 
thrombolysis :s 180 minutes (n = 22). D, Regional contribution 
of the inferior wall to global ejection fraction at the chronic stage 
in the thrombolysis group (n = 79), according to the initial success 
and late patency after thrombolysis either with or without angio· 
plasty. -. - = Unsuccessful thrombolysis (n == 31); - = sue· 
cessful thrombolysis (n == 41); ... == angioplasty after successful 
thrombolysis (n == 7). 
intervention failed. Such bias can be overcome only by 
means of randomized trials and analysis of the data on an 
"intention to treat" basis. However, in such a trial it is 
poster 1 or (%) 
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difficult to follow the sequence: determination of patient 
eligibility, coronary arteriography, randomization and at•
tempted reperfusion in patients randomized to special ther•
apy. In this sequence, patients with an evolving infarction 
who are randomized to conventional therapy would be obliged 
to undergo emergency coronary arteriography without suf•
ficient potential benefit to outweigh the attendant risk. To 
overcome this difficulty we randomized all patients who 
were eligible on clinical grounds but obtained consent for 
performing coronary arteriography only from those assigned 
to reperfusion therapy. This procedure has been proposed 
by Zelen (31) for the comparison of a new method of treat•
ment with an accepted mode of therapy. 
Because angiography was not initially performed in the 
control group, radionuclide angiography was carried out at 
the bedside on the first or second day after admission and 
repeated before hospital discharge in the control group as 
well as in the thrombolysis group (Simoons et aL, unpub· 
lished observations). The results indicate no change in global 
left ventricular ejection fraction between the second day and 
hospital discharge in the control group. In the thrombolysis 
group left ventricular ejection fraction before discharge was 
3.7% higher than during the first measurement. Accord· 
ingly, left ventricular ejection fraction after 10 to 20 days 
lACC Vol 7. No 4 
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Table 7. Left Ventncular HemodynamIcs in Anterior Infarction Before Discharge 
HR (bpm) 
Mean AoP (mm Hg) 
EDP (mm Hg) 
EDV (ml/m') 
ESV (mllm') 
EF (%) 
SV (mllm') 
CI (liten,/mm per m') 
AbbreVlallons as in Table 4. 
Controb (n = 69) 
79 :t 13 
87 :t 13 
21 :t to 
101 :t 39 
60 :t 34 
43 :t 14 
41 :t 16 
3.2 :t I 3 
was approximately 4% higher when thrombolysis was com•
pared with conventional treatment. This difference was sig•
nificant in the whole group, in patients treated with intra•
coronary thrombolysis only, in patients with a first infarction 
and in both anterior and inferior infarction. In fact, the 
beneficial effects of thrombolysis in the currently reported 
trial gain great significance as infarct size, ventricular func•
tion and survival all were found to be significantly improved 
when the "intention to treat" principle was applied to con•
secutive patients. 
Comparison with previous randomized trials. The re•
sults of the five reported but smaller randomized trials with 
intracoronary streptokinase (13,15,17-19) conflict with the 
data presented here. Khaja et al. (13) found that intracor•
onary streptokinase was more effective than placebo (intra•
coronary infusion of dextrose) in achieving reperfusion, but 
they detected no difference in left ventricular function at 12 
days and at 5 months. Three of the studies (15.17.19) also 
demonstrated no difference in the radionuclide ejection frac•
tion at discharge in patients with anterior or inferior myo•
cardial infarction treated with intracoronary streptokinase 
or in control patients, although they achieved reperfusion 
and a decreased mortality. In all these studies the interven•
tion was instituted much later than in our current one. The 
median interval between the onset of symptoms and angJO•
graphic documentation of a patent infarct-related vessel in 
the present study was 200 minutes while the other two major 
trials (14,20) included patients up to 12 hours after the onset 
of symptoms. In the studies of Khaja et al. (13) and Raizner 
et al. (19) the time period between chest pain and onset of 
infusion of streptokinase was 5.4 and 5.6 hours, respec•
tively. In the Western Washington trial (15,16) the mean 
time to randomization and the start of streptokinase infusion 
was 276 minutes, while Rentrop et a1. (18) started intra•
coronary streptokinase an average of 350 minutes after the 
onset of symptoms. The shorter delay achieved in our study 
is also reflected by the higher recanalization rate (79%) 
compared with that in the Western Washington trial (68 % ). 
These differences from the Western Washington trial, the 
only other large (250 patients) randomized trial, may be 
crucial, because they confirm experimental data (44) that 
Thromboly~is (n = 79) P Value 
77 :t 13 NS 
89 :t 14 NS 
21 :t 9 NS 
86 :t 34 002 
45 :t 29 0.006 
50 :t 13 0.0025 
42 :t 15 NS 
,) + I I NS 
recovery of ischemic myocardium cannot be achieved after 
4 hours of coronary occlusion. As recurrent episodes of 
occlusion alternating with spontaneous reperfusion may oc•
cur in some patients (45), it remains possible that the sal•
utary effect of thrombolysis in such patients extends beyond 
4 hours. However, such beneficial influences are completely 
outweighed by the inability to achieve recovery of function 
and tissue injury in the majority of patients and the increased 
chance of reperfusion injury as ischemic time lengthens. 
Schwartz et a1. (41) clearly demonstrated no benefit from 
late reperfusion (4 hours), a finding in agreement with all 
animal experiments (3,46,47). Previous data (14,41) and 
our data agree in demonstrating streptokinase to have a 
major beneficial effect on left ventricular function, provided 
it is given within 4 hours after onset of symptoms. 
The magnitude of change in regional function in the 
infarct zone was also significantly influenced by the time 
elapsed between the onset of chest pain and actual reca•
nalization. Patients with an infarct-related vessel recanalized 
within 3 hours had significantly greater improvement than 
patients treated later. The regional contribution to ejection 
fraction of the infarct zone improved by at least 1.5% in 
patients treated within 3 hours with either anterior or inferior 
infarction. As recently demonstrated by Mathey et a1. (48), 
thrombolysis should be administered within 2 hours after 
the onset of symptoms to obtain maximal recovery of ven•
tricular function. 
The inclusion of mechanical perforation and translumi•
nat coronary angioplasty as part of the recanalization pro•
cedure and the introduction of intravenous administration 
of streptokinase in the second treatment arm before cardiac 
catheterization provide major differences from previously 
reported studies. Transluminal coronary angioplasty was 
employed in two of the five hospitals that had extensive 
experience with this procedure. It was carried out to prevent 
reocclusion when residual vessel obstruction was considered 
to be 60% or more after thrombolysis (25,26). Patients so 
treated had a lower mortality and a lower incidence of rein•
farction than did patients successfully treated with strep•
tokinase alone. Although these results may be biased by the 
selection of patients who had lesions suitable for translu-
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Figure 4. A, The mean values of regional contribution to ejection 
fraction in patients with anterior infarction are shown as in Figure 
3. The regional pump function of the anterobasal. anteroapical and 
inferoapical segments (l to 10, II to 15) is significantly better in 
the thrombolysis group (n = 79, solid line), compared with con•
ventional treatment (n = 69, dotted line). B, Change in regional 
contribution to ejection fraction from the acute (solid line) to the 
chronic (dotted line) stage in patients (n == 17) with an anterior 
infarction who underwent a combined procedure of recanalization 
and angioplasty. C, Regional contribution of the anterior wall to 
global ejection fraction at the chronic stage in the control and the 
thrombolysis group, according to the success of the recanalization 
at the acute stage and to the time elapsed from the onset of 
symptoms to treatment. Control (n 69); 
--- = thrombolysis> 180 minutes (n = 40); - == thrombolysis 
:s; 180 minutes (n = 24). D, Regional contribution of the anterior 
wall to global ejection fraction at the chronic stage in the throm•
bolysis group (n = 79), according to the initial and late patency 
after successful thrombolysis either with or without angioplasty. 
-.- = Unsuccessful thrombolysis (n == 15); - == successful 
thrombolysis (n == 44); ... == angioplasty after successful throm•
bolysis (n = 20). 
minal coronary angioplasty and who were hemodynamically 
stable after thrombolysis, the data are in agreement with 
earlier observations (21 ,49) that the recovery of regional 
left ventricular function is greatest in patients with minimal 
posterlur (;.) 
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residual stenosis after the intervention. Experimental studies 
(50) also have shown that restriction of flow during reper•
fusion results in relative underperfusion of, and continued 
ischemia in, the subendocardium. 
Analysis of global and regional wall motion. 
Measurement of the global ejection fraction is a rather crude 
method that may not detect improvement in regional left 
ventricular function. Therefore, analysis of left ventricular 
wall motion in the infarct area at risk, which potentially 
should benefit most from reperfusion, must be carried out 
to detect any real effect of reperfusion (21,51,52). In fact, 
increased motion of the noninfarcted regions of the heart 
often kept the global ejection fraction within normal limits 
despite severe regional hypokinesia in the infarct area. Con•
tractile performance of the noninfarcted area may be en•
hanced by the Frank-Starling mechanism and by increased 
levels of circulating catecholamines in the first hours after 
infarction. After subsidence of compensatory augmented 
motion in the noninfarct regions of the heart. which masked 
significant deterioration in regional wall motion, initially 
maintained global left ventricular function declined. Here, 
again, regional wall motion must be measured to adequately 
assess this effect. Significant improvement of regional func•
tion in the "infarct zone" was observed in inferior as well 
JACC Vol. 7, No.4 
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Table 8. Thrombolysis Group: Serial Left Ventricular Hemodynamics 
Acute p Value Chronic Acute p Value Chronic 
A. Anterior Infarction (n = 38) 
Successful (n = 34) Unsuccessful (n = 4) 
HR (bpm) 84 ± 13 0.007 75 ± 14 84 ± 16 NS 80 ± 3 
Ao (mm Hg) 82 ± 12 0.07 85 ± 9 87 ± 12 NS 89 ± 30 
EDP (mm Hg) 23 ± 10 0.06 19 ± 8 22 ± 9 NS 26 ± 8 
EDV (mllm2) 81 ± 32 NS 83 ± 27 58 ± 22 NS 77 ± II 
ESV (mllm2) 42 ± 24 NS 41 ± 22 28 ± 9 NS 39 ± 4 
EF(%) 49 ± II 0.06 53 ± 12 50 ± 9 NS 48 ± 7 
SV (mllm2) 38 ± 14 0.04 42 ± 13 30 ± 15 NS 38 ± 10 
CI (liters/mill per m2) 3.2 ± \.1 NS 3.1 ± I 1 2.4 ± 09 NS 3.0 ± 0.7 
B. Inferior Infarction (n = 44) 
Successful (n = 29) Unsuccessful (n = 15) 
HR (bpm) 82 ± \3 0.02 75 ± II 87 ± 21 0.03 75 ± 13 
Ao (mm Hg) 86 ± 15 0.02 94 ± 10 85 ± 10 NS 87 ± 15 
EDP (mm Hg) 18 ± 8 NS 19 ± 9 20 ± \0 NS 19 ± 8 
EDV (mlim2) 71 ± 22 NS 78 ± 29 74 ± 27 0.0003 93 ± 28 
ESV (mllm2) 27 ± II 0.05 32 ± 15 37 ± 19 0.0006 48 ± 26 
EF (%) 61 ± 9 NS 60 ± 8 55 ± \0 0.004 51 ± II 
SV (mllm2) 43 ± 16 NS 46 ± 16 40 ± 15 0.08 45 ± 9 
CI (liters/min per m2) 3.6 ± 1.3 NS 3.5 ± 1.2 3.4 ± 1.4 NS 3.3 ± 0.8 
Values are expressed as mean ± SD; Student t test for paired data. Abbreviations as III Table 4. 
as anterior locations although significant changes in regional 
function of the remote noninfarct zone occurred at the acute 
as well as the chronic stage. 
The analysis of regional left ventricular function was 
based on automated, high resolution, frame to frame edge 
Figure 5. Changes in regional contribution to global 
ejection fraction of the infarct ZOl'\e (CREF-IZ, %) 
(anterior: segments 1 to 10; inferior: 11 to 20) be•
tween the acute phase an<l the late control. Right, 
Patients with either unsuccessful recanalization or 
late reocclusion (UNSUCC. PTCR). Middle, Pa•
tients with successful recanalization and late pat•
ency of the infarct related vessel (SUCC. PTCR). 
Left, Patients who underwent a successful reca•
nalization, immediately followed by angioplasty 
(PTCR + PTCA). p values < 0.05 are reported 
(paired or unpaired Student's t test). glob. EF = 
global ejection fraction; A = relative increment or 
decrement. 
N 
detection of left ventricular contour. This system allows fast 
and reliable acquisition of single left ventricular contour, 
every 20 ms, all over a complete cardiac cycle (33,34). 
Many wall motion models have been proposed to approx•
imate actual endocardial motion; this reflects the problems 
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RADIONUCLIDE EJECTION FRACTION (%) 
Figure 6. One year mortality as a function of radionuclide ejection 
fraction (%) measured at hospital discharge after acute myocardial 
infarction. The solid line between the dashed lines indicates the 
corresponding 95% confidence interval. The calculations are based 
on pooled data from the Multicenter Postinfarction Study (60) and 
the Thoraxcenter (Fioretti P. personal communication, 1985). 
investigators have had in establishing a geometric frame•
work from which to judge whether the motion of the en•
docardial contour is normal or abnormal (53). All these 
methods assess wall motion in terms of extent of shortening 
at specific points on an axis reference system, although it 
is highly unlikely that a particular endocardial site coincides 
with one of these axes during the entire cardiac cycle. The 
wall motion analysis system we used is based on the motion 
pattern of small irregularities at the left ventricular endo•
cardial border (endocardial landmarks) that can be detected 
in the contrast cineangiogram with the automated endocar•
dial outlining system (33,34). This endocardial landmark 
pathway was tested previously in 23 normal human left 
ventricles and validated in pigs with metal endocardial mark•
ers inserted with a percutaneous, retrograde, trans vascular 
approach (23.54). This wall motion analysis is unaffected 
by the translation and rotation of the heart, thus permitting 
an actual study of the segmental wall motion and derived 
variables. 
50 
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Early after myocardial infarction. the uninvolved portion 
of the heart is generally thought to maintain normal function 
and metabolism. unless coexisting stenosis of additional 
vessels causes ischemia of the noninfarcted segments (55). 
Yet, after experimental myocardial infarction, the clearly 
nonischemic portions of the heart muscle also show changes 
in energy metabolism and a decline in norepinephrine con•
tent (56,57). Other investigators have reported decreased 
lactate extraction and ischemic histologic changes, such as 
swelling of mitochondria or reduction in tissue glycogen 
content, in areas of myocardium remote from the site of 
coronary occlusion. However, when the infarcted area is 
reperfused early, the decline in contractility of noninfarcted 
heart muscle appears to be reversible, but this is limited to 
the early postinfarction period (10 days) (58). Other data 
(59), during and after open heart surgery, indicate that a 
longer delay of up to 4 weeks might be needed to achieve 
a full recovery, This overall improvement in the ischemic 
areas and the high patency (85%) of the infarct-related artery 
after the intervention, as well as other aspects of the design 
of our study, show the major significance of early recanal•
ization in order to achieve the goal of preservation of left 
ventricular function. The results of our study also indicate 
that reperfusion may need to be supplemented by revas•
cularization procedures such as angioplasty to optimize the 
chances of obtaining full functional recovery. The beneficial 
effects of early thrombolysis evident in this large series of 
lACC Vol 7, No 4 
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patients studied over an extended time period might explain 
the observed reduction (from 16 to 9%) in 1 year mortality 
(l2,12a). 
Prognostic implications. The multicenter postinfarc•
tion research group (60) reported that patients with higher 
global ejection fraction had better 1 year survival after myo•
cardial infarction independent of the extent of coronary dis•
ease. Similar data were found in a follow-up study of 449 
hospital survivors at the Thoraxcenter (Fioretti p, personal 
communication, 1985). Pooling the results of these studies, 
a curvilinear relation between the I year mortality rate and 
global ejection fraction can be constructed (Fig. 6). When 
the currently observed improvement of left ventricular ejec•
tion fraction from 47% in control patients (estimated prob•
ability of cardiac death = 0.050) versus 53% in patients 
allocated to thrombolysis (estimated probability of cardiac 
death = 0.037) is interpreted in this manner, the I year 
mortality should indeed be reduced by 24% after throm•
bolysis, a projection that corresponds to our observations. 
Thus, the explanation for the reduced mortality must mainly 
be ascribed to the restoration of left ventricular function, 
rather than to any other mechanism. 
Appendix 
Participating Centers and Collaborators 
Thoraxcenter, Erasmus University and University Hospital Dijk•
zigt, Rotterdam. Marcel J.B.M. vd Brand, MD. Plm J. de Feyter. MD. 
Paolo Fioretti, MD, Paul G Hugenholtz. MD. Patrick W. Serruys. MD. 
Maarten I. Simoons. MD. William Wljns, MD. 
Department of Cardiology, Free UniverSity, Amsterdam. Machlel 
J. van Eenige. MSc. Jan C.J. Res. MD. Jan P. Roos, MD. Freek W.A. 
Verheught, MD. Frans C Visser. MD. Ernst E. vd Wall, MD 
Department of Cardiology, Zuiderziekenhuis, Rotterdam. Dlederik 
CA. van Hoogenhuyze, MD. X. Hanno Krauss. MD. Willem J Remme. 
MD 
Department of Cardiology, St. Annadal Hospital, Maastricht. Frits 
W.H.M. Bar, MD. Simon H.l.G. Braat. MD. Pedro Brugada. MD, Karel 
den Dulk. MD, Wim T. Hermem" MSc, Hem 11 Wellens. MD. Chm 
de Zwaan, MD. 
Department of Cardiology, University Hospital, Leiden. Berend 
Buis. MD, los G. Engbers, MD. Arnoud vd Laarse. PhD 
Data Processing Center, Thoraxcenter, Erasmus University, Rot•
terdam. Sophie vd Does. Ron T van Domburg. MSc. lacobus Lubsen, 
PhD. Ian P van Mantgem. MD, Karel 1. de Neef, MD. luan Planellas, 
MD, Frank Vermeer. MD. Anneke A. Wagenaar. Inge C 1. Zorn. 
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